Drug Discovery World

DECEMBER 7, 2022

Data analytics company Phesi analysed 2,358 clinical trials involving collagen. In the first 10 months of 2022, there were more than 225 new trials, compared with 125 in 2012. billion by 2028. Phesi’s analysis shows that just 27% of trials received industry funding. billion USD, and is expected to grow to $16.7

Clinical Trials 130

Clinical Trials Trials Clinical Research Clinical Development 130

Drug Discovery World

SEPTEMBER 28, 2022

In fact, the market research firm, Bekryl, predicts that AI has the potential to offer over $70 billion in savings for the drug discovery process by 2028. . For the wider industry, what we are likely to see as a result is that smaller biotechnology companies are pushed to focus on more niche research. .

Pharma Companies 130

Pharma Companies Hospitals Clinical Trials Drugs 130

The Premier Consulting Blog

NOVEMBER 20, 2023

Clinical development experts would need to navigate the potential complexities arising from this regulatory shift, particularly in terms of trial design and evidence generation. Our team is helping clients navigate the changing regulations and clinical research.

Laboratories 52

Laboratories FDA Clinical Development Regulations 52

Drug Discovery World

AUGUST 10, 2022

In 1987, researchers developed the chimeric antigen receptor (CAR) as an alternative means to identify cancer cells and direct T cells to attack them. And now, with more than 600 CAR T trials recruiting or ongoing, these cells represent a majority of the cellular immunotherapies in development today. Training T cells to target tumours.

Therapies 246

Therapies Virus Treatment Engineering 246